Award

National Framework Agreement for Adalimumab Injection 1 April 2023

NHS ENGLAND

This public procurement record has 2 releases in its history.

Award

24 Mar 2023 at 11:45

Tender

26 Oct 2022 at 14:03

Summary of the contracting process

The National Framework Agreement for Adalimumab Injection commencing on 1 April 2023 is a completed procurement project by NHS England. The agreement covers multiple regions including South of England, Midlands and East, London, and North of England. It includes options for extensions up to 24 months, with various contract periods for each lot. The procurement method used was an open procedure, with award criteria based on price. The main procurement category is goods within the pharmaceutical products industry.

This tender offers significant business opportunities for pharmaceutical companies looking to supply Adalimumab Injection to NHS regions in England. The procurement process involves active supplier involvement, as evidenced by multiple awards made to companies like Amgen Ltd, Sandoz Ltd, Biogen, Abbvie Ltd, Fresenius Kabi Limited, and Celltrion Healthcare United Kingdom Limited. Businesses interested in this opportunity should consider registering their interest on the NHS eTendering portal and complying with the submission requirements before the bid validity period ends on 26th February 2023.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

National Framework Agreement for Adalimumab Injection 1 April 2023

Notice Description

Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023<br/> <br/>Offer reference number: CM/PHR/22/5660<br/> <br/>CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Lot Information

CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab

Lot 4 - CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab

Lot 3 - CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to the London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab

Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab

Lot 1 - CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents

Options: Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-037c6c
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/008624-2023
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£478,880,000 £100M-£1B
Lots Value
£478,880,000 £100M-£1B
Awards Value
Not specified
Contracts Value
£1

Notice Dates

Publication Date
24 Mar 20232 years ago
Submission Deadline
28 Nov 2022Expired
Future Notice Date
Not specified
Award Date
14 Mar 20232 years ago
Contract Period
31 Mar 2023 - 31 Aug 2024 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS ENGLAND
Contact Name
Katie Noonan
Contact Email
katie.noonan@nhs.net
Contact Phone
Not specified

Buyer Location

Locality
LEEDS
Postcode
LS2 7UE
Post Town
Leeds
Country
England

Major Region (ITL 1)
TLE Yorkshire and The Humber
Basic Region (ITL 2)
TLE4 West Yorkshire
Small Region (ITL 3)
TLE42 Leeds
Delivery Location
Not specified

Local Authority
Leeds
Electoral Ward
Little London & Woodhouse
Westminster Constituency
Leeds Central and Headingley

Supplier Information

Number of Suppliers
6
Supplier Names

ABBVIE

AMGEN

BIOGEN

CELLTRION HEALTHCARE UNITED KINGDOM

FRESENIUS KABI

SANDOZ

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-037c6c-2023-03-24T11:45:23Z",
    "date": "2023-03-24T11:45:23Z",
    "ocid": "ocds-h6vhtk-037c6c",
    "description": "RESPONDING TO THIS NOTICE;<br/>Any supplier may be disqualified who does not respond to the following in the requisite manner:<br/>1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.uk<br/>Candidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through the eTendering portal as follows:<br/>1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:<br/>- agree to the user agreement<br/>- populate company details<br/>1.2) Once registered, candidates must register interest as follows:<br/>- log to the portal<br/>- select \"Find Opportunities\" from the supplier home screen, use the \"Sort by:\" facility to find this opportunity and select the bold blue title to select<br/>- review opportunity details and click \"Register Interest\"<br/>- as you select the opportunity, you can review documents, send clarification messages, submit the response or decline to respond (if you decide not to participate in the opportunity)<br/>1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.<br/>2) General supplier information.<br/>To manage and assess supplier information the Contracting Authority requests candidates provide their<br/>company profile in the Government's Supplier Registration Service (which has replaced sid4gov), as follows:<br/>2.1) If not already registered (the previous sid4gov password, login and details will still<br/>be on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.uk<br/>and select \"Register\" at the top of the page.<br/>Key in details as requested to search for your company. If you do not have a D-U-N-S(r) Number, click on the link at the right of the page to obtain a number from D&B.<br/>Candidates must obtain a Dun & Bradstreet (D&B) D-U-N-S(r) Number to enable registration on the system.<br/>2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.<br/>D&B data will be supplied automatically by D&B.<br/>2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via the<br/>message function on the website.<br/>OTHER CONTRACTING AUTHORITIES<br/>The framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.",
    "initiationType": "tender",
    "tender": {
        "id": "CM/PHR/22/5660",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "National Framework Agreement for Adalimumab Injection 1 April 2023",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "mainProcurementCategory": "goods",
        "description": "Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023<br/> <br/>Offer reference number: CM/PHR/22/5660<br/> <br/>CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months",
        "value": {
            "amount": 478880000,
            "currency": "GBP"
        },
        "lots": [
            {
                "id": "4",
                "title": "CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab",
                "description": "Lot 4 - CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to the North of England. Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents",
                "value": {
                    "amount": 159715000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "startDate": "2023-04-01T00:00:00+01:00",
                    "endDate": "2026-02-28T23:59:59Z"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "allowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months"
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                }
            },
            {
                "id": "3",
                "title": "CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab",
                "description": "Lot 3 - CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to the London. Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents",
                "value": {
                    "amount": 87860000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "startDate": "2023-04-01T00:00:00+01:00",
                    "endDate": "2025-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "allowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months"
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                }
            },
            {
                "id": "2",
                "title": "CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
                "description": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East. Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents",
                "value": {
                    "amount": 133011000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "startDate": "2023-04-01T00:00:00+01:00",
                    "endDate": "2025-02-28T23:59:59Z"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "allowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months"
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                }
            },
            {
                "id": "1",
                "title": "CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab",
                "description": "Lot 1 - CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England. Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents",
                "value": {
                    "amount": 98294000,
                    "currency": "GBP"
                },
                "contractPeriod": {
                    "startDate": "2023-04-01T00:00:00+01:00",
                    "endDate": "2024-08-31T23:59:59+01:00"
                },
                "hasRenewal": false,
                "submissionTerms": {
                    "variantPolicy": "allowed"
                },
                "hasOptions": true,
                "options": {
                    "description": "Option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months"
                },
                "status": "cancelled",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                }
            }
        ],
        "items": [
            {
                "id": "4",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "4",
                "deliveryLocation": {
                    "description": "Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points"
                }
            },
            {
                "id": "3",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "3",
                "deliveryLocation": {
                    "description": "Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points"
                }
            },
            {
                "id": "2",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "2",
                "deliveryLocation": {
                    "description": "Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points"
                }
            },
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK"
                    },
                    {
                        "region": "UK"
                    }
                ],
                "relatedLot": "1",
                "deliveryLocation": {
                    "description": "Please refer to Document No. 03, Schedule 8 in the ITO Documents for the list of Purchasing Points"
                }
            }
        ],
        "submissionMethod": [
            "electronicSubmission",
            "written"
        ],
        "submissionMethodDetails": "https://health-family.force.com/s/Welcome",
        "communication": {
            "atypicalToolUrl": "https://health-family.force.com/s/Welcome"
        },
        "procurementMethod": "open",
        "procurementMethodDetails": "Open procedure",
        "techniques": {
            "hasFrameworkAgreement": true
        },
        "coveredBy": [
            "GPA"
        ],
        "tenderPeriod": {
            "endDate": "2022-11-28T13:00:00Z"
        },
        "submissionTerms": {
            "languages": [
                "en"
            ],
            "bidValidityPeriod": {
                "endDate": "2023-02-26T23:59:59Z"
            }
        },
        "awardPeriod": {
            "startDate": "2022-11-28T13:00:00Z"
        },
        "bidOpening": {
            "date": "2022-11-28T13:00:00Z",
            "address": {
                "streetAddress": "Runcorn"
            },
            "description": "Commercial Medicines Unit Employee"
        },
        "hasRecurrence": false,
        "contractTerms": {
            "hasElectronicOrdering": true,
            "electronicInvoicingPolicy": "allowed",
            "hasElectronicPayment": true
        }
    },
    "parties": [
        {
            "id": "GB-FTS-3022",
            "name": "NHS England",
            "identifier": {
                "legalName": "NHS England"
            },
            "address": {
                "streetAddress": "Quarry House, Quarry Hill",
                "locality": "Leeds",
                "region": "UK",
                "postalCode": "LS2 7UE",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Katie Noonan",
                "email": "katie.noonan@nhs.net",
                "url": "https://health-family.force.com/s/Welcome"
            },
            "roles": [
                "buyer",
                "centralPurchasingBody"
            ],
            "details": {
                "url": "https://www.england.nhs.uk/",
                "buyerProfile": "https://www.england.nhs.uk/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "MINISTRY",
                        "description": "Ministry or any other national or federal authority, including their regional or local subdivisions"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-FTS-497",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "email": "generaloffice@administrativecourtoffice.justice.gov.uk"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.gov.uk/courts-tribunals"
            }
        },
        {
            "id": "GB-FTS-77520",
            "name": "Amgen Ltd",
            "identifier": {
                "legalName": "Amgen Ltd",
                "id": "2354269"
            },
            "address": {
                "streetAddress": "216 Science Park Milton Road",
                "locality": "Cambridge",
                "region": "UK",
                "postalCode": "CB4 0WA",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-78343",
            "name": "Sandoz Ltd",
            "identifier": {
                "legalName": "Sandoz Ltd",
                "id": "01547204"
            },
            "address": {
                "streetAddress": "Park View, Riverside Way, Watchmoor Park,",
                "locality": "Camberley, Surrey.",
                "region": "UK",
                "postalCode": "GU15 3YL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "sme"
            }
        },
        {
            "id": "GB-FTS-77512",
            "name": "Biogen",
            "identifier": {
                "legalName": "Biogen",
                "id": "01497267"
            },
            "address": {
                "streetAddress": "Innovation House 70 Norden Road",
                "locality": "Maidenhead Berkshire",
                "region": "UK",
                "postalCode": "SL6 4AY",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-77553",
            "name": "Abbvie Ltd",
            "identifier": {
                "legalName": "Abbvie Ltd",
                "id": "08004972"
            },
            "address": {
                "streetAddress": "Abbvie House, Vanwall Business Park, Vanwall Road,",
                "locality": "Maidenhead, Berks.",
                "region": "UK",
                "postalCode": "SL6 4UB",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-78344",
            "name": "Fresenius Kabi Limited",
            "identifier": {
                "legalName": "Fresenius Kabi Limited",
                "id": "2182135"
            },
            "address": {
                "streetAddress": "Cestrian Court, Eastgate Way, Manor Park,",
                "locality": "Runcorn, Cheshire,",
                "region": "UK",
                "postalCode": "WA7 1NT",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-77560",
            "name": "Celltrion Healthcare United Kingdom Limited",
            "identifier": {
                "legalName": "Celltrion Healthcare United Kingdom Limited",
                "id": "11685363"
            },
            "address": {
                "streetAddress": "The Switch ,1-7 The Grove,",
                "locality": "Slough",
                "region": "UK",
                "postalCode": "SL1 1QP",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "GB-FTS-1661",
            "name": "The High Court",
            "identifier": {
                "legalName": "The High Court"
            },
            "address": {
                "streetAddress": "The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL",
                "countryName": "United Kingdom"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://www.judiciary.uk/courts-and-tribunals/high-court/"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-3022",
        "name": "NHS England"
    },
    "language": "en",
    "awards": [
        {
            "id": "008624-2023-1",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-77520",
                    "name": "Amgen Ltd"
                }
            ]
        },
        {
            "id": "008624-2023-2",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-78343",
                    "name": "Sandoz Ltd"
                }
            ]
        },
        {
            "id": "008624-2023-3",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-77512",
                    "name": "Biogen"
                }
            ]
        },
        {
            "id": "008624-2023-4",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-77553",
                    "name": "Abbvie Ltd"
                }
            ]
        },
        {
            "id": "008624-2023-5",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-78344",
                    "name": "Fresenius Kabi Limited"
                }
            ]
        },
        {
            "id": "008624-2023-6",
            "relatedLots": [
                "2"
            ],
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-FTS-77560",
                    "name": "Celltrion Healthcare United Kingdom Limited"
                }
            ]
        }
    ],
    "contracts": [
        {
            "id": "008624-2023-1",
            "awardID": "008624-2023-1",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        },
        {
            "id": "008624-2023-2",
            "awardID": "008624-2023-2",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        },
        {
            "id": "008624-2023-3",
            "awardID": "008624-2023-3",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        },
        {
            "id": "008624-2023-4",
            "awardID": "008624-2023-4",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        },
        {
            "id": "008624-2023-5",
            "awardID": "008624-2023-5",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        },
        {
            "id": "008624-2023-6",
            "awardID": "008624-2023-6",
            "title": "Lot 2 - CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab",
            "status": "active",
            "value": {
                "amount": 1,
                "currency": "GBP"
            },
            "dateSigned": "2023-03-14T00:00:00Z"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "6",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "11",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "16",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "21",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "26",
                "measure": "bids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "2",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "7",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "12",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "17",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "22",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "27",
                "measure": "smeBids",
                "relatedLot": "2",
                "value": 1
            },
            {
                "id": "3",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "8",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "13",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "18",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "23",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "28",
                "measure": "foreignBidsFromEU",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "4",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "9",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "14",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "19",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "24",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "29",
                "measure": "foreignBidsFromNonEU",
                "relatedLot": "2",
                "value": 0
            },
            {
                "id": "5",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "10",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "15",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "20",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "25",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            },
            {
                "id": "30",
                "measure": "electronicBids",
                "relatedLot": "2",
                "value": 7
            }
        ]
    }
}